Aconex Share Price Jumps 44% in One Day

By ,

Making 44% in a day is an amazing return.

Such returns are usually associated with tiny speculative stocks, or cryptocurrencies. But this morning it was Aconex Ltd [ASX:ACX], a billion-dollar construction software company, that jumped up 44%.

Aconex share price rise

Source: Google Finance

What happened to Aconex share price?

This morning Aconex said that they’ll sell the business to Oracle Corporation [NYSE:ORCL], a global cloud software service provider.

Oracle made a bid of $7.8 per share for the business, 47% higher than Aconex’s previous trading price. As reported by The Australian:

The deal will see Aconex’s (ACX) platform become part of the Oracle construction and engineering cloud, which offers planning, scheduling project delivery solutions.

According to Oracle, the combination of Aconex with its existing offer will create the most comprehensive cloud-based project management solution targeting the global $14 trillion construction industry.’

What now for Aconex?

It’s a little sad that Aconex is being sold off. I’m sure shareholders are happy with the offer price. But now they’ll never know what could have been.

Aconex was expanding into the lucrative Chinese construction market. The company was growing sales rapidly. Had they been able to control costs, the business might have sold for a lot more than $7.8 per share.


Härje Ronngard,

Junior Analyst, Money Morning

PS: What to find more stocks with huge growth potential. Check out these three small-cap stocks trading on the ASX. They could rapidly grow over the next few months.

About Money Morning Editorial

Money Morning is Australia’s most outspoken financial news service. Your Money Morning editorial team are not afraid to tell it like it is. From calling out politicians to taking on the housing industry, our aim is to cut through the hype and BS to help you make sense of the…

Bubs Announces $68 Million Capital Raise

[ASX:BUB] is rattling the can to raise $68 million to support ‘growth opportunities.’

Is Stock Analysis Worth It? Finding Your Investment Edge

Is stock analysis worth your time? The question boils down to a key academic topic: market efficiency.

Bubs (ASX:BUB) Shares up on US Supply Deal Update

Infant nutrition producer Bubs Australia [ASX:BUB] came out with another supplier update today, signing supply agreements with two more US retailers.

NeuRizer [ASX:NRZ] Shares Soar on $1.5 Billion Binding Offtake

NeuRizer [ASX:NRZ] opened 35% higher on Monday after announcing a binding $1.5 billion offtake agreement with Daelim.

[WATCH] Closing Bell — In the Eye of the Storm

It’s a sea of bad news out there at the moment. Equities have cracked and they are continuing to drift lower.

AVZ Minerals Extends Voluntary Suspension

Lithium developer AVZ Minerals [ASX:AVZ] has extended its voluntary suspension on Friday as it continues to work through regulatory and ownership issues concerning its Manono Lithium Project.